Protecting IP in the Pharmaceutical Industry
With the cost of bringing a new drug to market now exceeding $2.5B, it should come as no surprise that pharmaceutical companies are increasingly targeted for their Intellectual Property (IP). As a result, companies are beginning to adopt Incident Response strategies centered around their IP.
Is your company’s Intellectual Property at Risk?
Download This White Paper to Learn:
- The Importance of a dedicated IP incident management team
- The tools and tactics for prioritizing IP security
- How to identify and assign value to critical IP Assets
- How to leverage proven incident handling procedures